In those non-MBL HD who had previously been infected withSARS-CoV-2, anti-S IgG and/or IgA antibodies were already detected at baseline in 68% and 80% of cases, respectively (Figure 5 and Supplementary Figure S12). This evidence concerns the gene CD79A and Huntington disease.